MALOX | RLBAX | MALOX / RLBAX | |
Total Expense Ratio | 0.87 | 1.31 | 66% |
Annual Report Gross Expense Ratio | 0.90 | 1.31 | 69% |
Fund Existence | 37 years | 23 years | - |
Gain YTD | 12.679 | 13.947 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 250 | 800,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17B | 266B | 6% |
Annual Yield % from dividends | 2.67 | 1.10 | 242% |
Returns for 1 year | 8.01 | 7.84 | 102% |
Returns for 3 years | 36.42 | 47.39 | 77% |
Returns for 5 years | 6.18 | 37.69 | 16% |
Returns for 10 years | 16.05 | 67.66 | 24% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QQMG | 41.65 | 0.31 | +0.74% |
Invesco ESG NASDAQ 100 ETF | |||
FHLC | 68.90 | 0.31 | +0.45% |
Fidelity MSCI Health Care ETF | |||
EWQ | 45.23 | 0.08 | +0.18% |
iShares MSCI France ETF | |||
GSIG | 47.91 | -0.03 | -0.05% |
Goldman Sachs Acs Inv Gd Cp 1-5Yr Bd ETF | |||
CERY | 28.82 | -0.15 | -0.50% |
SPDR Blmbrg Enh Roll Y Cmd Stgy NoK-1ETF |